The hallmark of MPN is the clonal hematopoiesis driven by acquired somatic mutations in myeloid progenitor cells, in particular phenotypic driver mutations in JAK2, CALR and MPL genes induce constitutive activation of intracellular JAK-STAT pathway. Here, JAK2 is linked to myeloproliferative disorder.